These results indicated that the ovarian cancer cells were more sensitive to DDP treatment under EEF1D loss-of-function conditions, of which the effect in EEF1D KO cells was more significant than that in EEF1D KD cells. Here, EEF1D is linked to ovarian carcinoma.